TY - JOUR
T1 - Long-term performance of the hemodialysis reliable outflow (hero) device
T2 - The 56-month follow-up of the first clinical trial patient
AU - Nassar, George M.
PY - 2010/3
Y1 - 2010/3
N2 - The Hemodialysis Reliable Outflow (HeRO®) Vascular Access Device is a novel long-term subcutaneous dialysis graft, ideally suited for catheter-dependent patients and patients dialyzing with failing fistulas or grafts due to venous outflow stenosis. This case presentation depicts the clinical course of the first patient to enter a Food and Drug Administration approved clinical trial and receive the HeRO device. The course of this patient over 56 months of follow-up provides the longest experience with the HeRO device to-date. In this patient, the HeRO device provided long-term dialysis access patency in conjunction with adequate dialysis and a low intervention rate.
AB - The Hemodialysis Reliable Outflow (HeRO®) Vascular Access Device is a novel long-term subcutaneous dialysis graft, ideally suited for catheter-dependent patients and patients dialyzing with failing fistulas or grafts due to venous outflow stenosis. This case presentation depicts the clinical course of the first patient to enter a Food and Drug Administration approved clinical trial and receive the HeRO device. The course of this patient over 56 months of follow-up provides the longest experience with the HeRO device to-date. In this patient, the HeRO device provided long-term dialysis access patency in conjunction with adequate dialysis and a low intervention rate.
UR - http://www.scopus.com/inward/record.url?scp=77953188606&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953188606&partnerID=8YFLogxK
U2 - 10.1111/j.1525-139X.2010.00713.x
DO - 10.1111/j.1525-139X.2010.00713.x
M3 - Article
C2 - 20525111
AN - SCOPUS:77953188606
SN - 0894-0959
VL - 23
SP - 229
EP - 232
JO - Seminars in Dialysis
JF - Seminars in Dialysis
IS - 2
ER -